Previous 10 | Next 10 |
The BlackRock Science & Technology II fund ( BSTZ ) , $19.43 current market price, $21.92 NAV, -11.4% discount, 6.2% current market yield , has only been around since last summer when it went public at $20 a share (both market and NAV prices) and already the fund's NAV has risen to ...
(This is our Weekly Commentary from May 3. All data is from that date. We send out our Weekly Commentaries every Sunday evening). Macro Picture Equities ended the week mixed although the last two days were fairly weak, ending on a dour note. There's clearly a tug of war going on as inves...
Written by Nick Ackerman, co-produced by Stanford Chemist BlackRock launched its fund the BlackRock Health Sciences Trust II ( BMEZ ) on January 29th, 2020. Roughly a month before the broader market had hit all-time highs and the COVID-19 crisis-induced selloff began. In hindsight, this ...
The Columbia Seligman Premium Tech Growth Fund ( STK ) is a closed-end fund ((CEF)) that invests in technology sector stocks. The fund utilizes an options selling strategy that supports its managed distribution policy that currently yields 9.2%, making STK an interesting vehicle for income-f...
The market has recovered quite a bit during the last couple of weeks and full 25% up from its lows on March 23. But by no means, we are out of the woods yet. However, a lot of people feel that there's some disconnect between the market action and the unprecedented economic upheaval and uncerta...
Written by Nick Ackerman, co-produced by Stanford Chemist We are continuing to navigate a volatile environment. Most are quite aware of the risks of the distribution cuts that will be coming down the pipeline shortly. We have already begun seeing cuts from some of the funds in the CEF wo...
Written by Nick Ackerman, co-produced by Stanford Chemist Throughout the massive COVID-19 selloff, Stanford Chemist and I have received several inquiries relating to the bankruptcy of closed-end funds or funds going "bust." As we aren't out of the woods yet with selloff pressures, now mi...
Closed-end-funds offer investors exposure to actively managed investment portfolios that oftentimes feature more dynamic strategies compared to passive ETFs. While many investors are attracted to the income profile of the various funds with corresponding impressively high yields and managed ...
BlackRock Science & Technology Trust (NYSE: BST ) declares $0.1655/share monthly dividend , in line with previous. Forward yield 7.0% Payable April 30; for shareholders of record April 15; ex-div April 14. See BST Dividend Scorecard, Yield Chart, & Dividend Growth. More...
These are the closed-end funds that I purchased when we hit the initial 10% correction territory. We have gone down further since. However, I believe these are still attractive names to be holding. Co-produced by Stanford Chemist It certainly has been a wild week for the market. We h...
News, Short Squeeze, Breakout and More Instantly...
BlackRock Science and Technology Trust of Beneficial Interest Company Name:
BST Stock Symbol:
NYSE Market:
BlackRock Science and Technology Trust of Beneficial Interest Website:
BlackRock Advisors, LLC released today share repurchase activity for certain BlackRock closed-end funds (the “Funds”) during the quarter ended June 30, 2022. The Funds have authorized open market share repurchase programs (the “Repurchase Programs”) pursuant ...
Today I want to show you how to build a “three-click” income portfolio that gives us three things every income investor craves, especially these days: Big discounts on our investments. Big dividends, with a 10.6% yield averaged out across three funds. Wide di...
With 2022 likely to be a wild ride, we income investors are going to lean on two key advantages. In doing so, we’ll secure 7% dividends no matter what the broader markets do. First, we can secure this “head start” by January 1 by purchasing funds that yield 7%, on a...